Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy R Smith

Headache

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Headache|November 20, 2015
In Memoriam--Robert E. Ryan, Sr., MDTimothy R Smith
Headache|March 21, 2002
Low-dose tizanidine with nonsteroidal anti-inflammatory drugs for detoxification from analgesic rebound headacheTimothy R Smith
Headache|February 13, 2010
Migraine education improves quality of life in a primary care settingTimothy R Smith, Robert A Nicholson, James W Banks
Headache|June 15, 2012
A sumatriptan iontophoretic transdermal system for the acute treatment of migraineJerome Goldstein, Timothy R Smith, Neil Pugach, et al.
Headache|February 23, 2012
Twelve-month tolerability and efficacy study of NP101, the sumatriptan iontophoretic transdermal systemTimothy R Smith, Jerome Goldstein, Richard Singer, et al.
Headache|August 7, 2021
STOP 301: A Phase 3, open-label study of safety, tolerability, and exploratory efficacy of INP104, Precision Olfactory Delivery (POD<sup>®</sup> ) of dihydroergotamine mesylate, over 24/52 weeks in acute treatment of migraine attacks in adult patientsTimothy R Smith, Paul Winner, Sheena K Aurora, et al.
Headache|August 20, 2005
Sumatriptan and naproxen sodium for the acute treatment of migraineTimothy R Smith, Abraham Sunshine, Stuart R Stark, et al.
Headache|February 16, 2007
Early intervention with almotriptan: results of the AEGIS trial (AXERT Early Migraine Intervention Study)Ninan T Mathew, Gary Finlayson, Timothy R Smith, et al.
Headache|October 24, 2009
Needle-free subcutaneous sumatriptan (Sumavel DosePro): bioequivalence and ease of useJan Lewis Brandes, Roger K Cady, Fred G Freitag, et al.
Headache|August 20, 2005
Acetaminophen, aspirin, and caffeine versus sumatriptan succinate in the early treatment of migraine: results from the ASSET trialJerome Goldstein, Stephen D Silberstein, Joel R Saper, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Headache|November 20, 2015
In Memoriam--Robert E. Ryan, Sr., MDTimothy R Smith
Headache|March 21, 2002
Low-dose tizanidine with nonsteroidal anti-inflammatory drugs for detoxification from analgesic rebound headacheTimothy R Smith
Headache|February 13, 2010
Migraine education improves quality of life in a primary care settingTimothy R Smith, Robert A Nicholson, James W Banks
Headache|June 15, 2012
A sumatriptan iontophoretic transdermal system for the acute treatment of migraineJerome Goldstein, Timothy R Smith, Neil Pugach, et al.
Headache|February 23, 2012
Twelve-month tolerability and efficacy study of NP101, the sumatriptan iontophoretic transdermal systemTimothy R Smith, Jerome Goldstein, Richard Singer, et al.
Headache|August 7, 2021
STOP 301: A Phase 3, open-label study of safety, tolerability, and exploratory efficacy of INP104, Precision Olfactory Delivery (POD<sup>®</sup> ) of dihydroergotamine mesylate, over 24/52 weeks in acute treatment of migraine attacks in adult patientsTimothy R Smith, Paul Winner, Sheena K Aurora, et al.
Headache|August 20, 2005
Sumatriptan and naproxen sodium for the acute treatment of migraineTimothy R Smith, Abraham Sunshine, Stuart R Stark, et al.
Headache|February 16, 2007
Early intervention with almotriptan: results of the AEGIS trial (AXERT Early Migraine Intervention Study)Ninan T Mathew, Gary Finlayson, Timothy R Smith, et al.
Headache|October 24, 2009
Needle-free subcutaneous sumatriptan (Sumavel DosePro): bioequivalence and ease of useJan Lewis Brandes, Roger K Cady, Fred G Freitag, et al.
Headache|August 20, 2005
Acetaminophen, aspirin, and caffeine versus sumatriptan succinate in the early treatment of migraine: results from the ASSET trialJerome Goldstein, Stephen D Silberstein, Joel R Saper, et al.
Pageof 2